Abstract:
An article in The Lancet discussed a clinical trial of a product for a rare disease. The authors had modified the primary analysis from an unadjusted Wilcoxon rank sum test to a Poisson regression. This led to several questions including: Was a Poisson distribution appropriate? How were the covariates selected? What is the effect of outliers (there were some)? If the Poisson model is not appropriate, can a permutation test approach provide information regarding the effect of the treatment? The presentation will show how Stata was used to evaluate these assumptions and provide an alternative analysis. The implications of this analysis are discussed.
More papers in North American Stata Users' Group Meetings 2005 from Stata Users Group Contact information at EDIRC. Series data maintained by Christopher F Baum ().
This site is part of RePEc
and all the data displayed here is part of the RePEc data set.
Is your work missing from RePEc? Here is how to
contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .